Publicació
RNA sequencing and Immunohistochemistry Reveal ZFN7 as a Stronger Marker of Survival than Molecular Subtypes in G-CIMP-negative Glioblastoma.
Veure totes les publicacions
RNA sequencing and Immunohistochemistry Reveal ZFN7 as a Stronger Marker of Survival than Molecular Subtypes in G-CIMP-negative Glioblastoma.
Results: RNA expression and low ZNF7 protein expression were strongly associated with longer survival, independently of molecular subtypes.
Conclusion: RNA expression and low ZNF7 protein expression were strongly associated with longer survival, independently of molecular subtypes.